Our preliminary studies showed that there were interactions between PRMT5 and HoxA9 in pathological cardiac hypertrophy and that HoxA9 was involved in the regulation of PRMT5 in cardiomyocyte hypertrophy. The gene discussed is HOXA9; the disease is cardiac hypertrophy.